Skip to content

#lab safety

5 public questions tagged with this topic.

UV light in biosafety cabinets is mainly used for:

Ultraviolet germicidal irradiation emitting at 254 nm wavelength is installed in many biosafety cabinets and transfer hoods as adjunct surface decontamination method. Photons absorbed by nucleic acids induce formation of cyclobutane pyrimidine dimers and 6-4 photoproducts between adjacent thymine or cytosine residues, blocking DNA polymerase progression and transcription, thereby inactivating bacteria, mycoplasma, fungal spores and viruses deposited on stainless steel or plastic work surfaces. Decontamination occurs only on directly illuminated surfaces with sufficient intensity and exposure time, typically 30 minutes when cabinet empty, blower off, and no personnel present because UV causes skin erythema, keratitis, and accelerates plastic degradation. UV does not sterilize liquids, penetrates poorly through organic debris, does not provide white light for microscopy, does not heat samples, and cannot replace HEPA airflow. Modern BSL-2 guidelines emphasize chemical disinfection with 70% ethanol or quaternary ammonium compounds as primary method, recommending UV only as secondary measure and advising against reliance for sterility assurance due to shadowing effects.

Ref: CDC BMBL 6th Ed Appendix A: Biosafety Cabinet UV light limitations; Alberts Molecular Biology of the Cell 6th Ed UV DNA damage chapter.

HEPA filters are used in biosafety cabinets to:

HEPA, High Efficiency Particulate Air filter, is fibrous mat of randomly arranged borosilicate fibers that captures airborne particles via interception, inertial impaction, and Brownian diffusion. In Class II biosafety cabinets, laminar flow hoods and CO2 incubators, HEPA filters provide 99.97% efficiency for most penetrating particle size of 0.3 micrometer, with even higher capture for smaller and larger particles including bacteria, fungal spores, dust and aerosolized cell fragments. In BSC, intake and exhaust HEPA filters deliver product protection for cultures and personnel protection by filtering exhaust before release to laboratory or outside. Filtration is purely physical; microorganisms trapped on filter matrix remain viable until filter is decontaminated by formaldehyde fumigation or hydrogen peroxide vaporization during cabinet certification. HEPA does not kill microbes by chemistry, does not control humidity, temperature, or gas composition, which are governed by humidifiers and infrared CO2 sensors. Periodic integrity testing using dispersed oil particulate challenge and measurement of face velocity at 100 lfpm ensures protection.

Ref: Lodish et al. Molecular Cell Biology 8th Ed Chapter 9 Cell Culture Methods; NSF/ANSI 49 Biosafety Cabinetry: HEPA filtration 99.97% at 0.3 µm.

Which biosafety level is required for routine animal cell culture?

Routine animal cell culture including work with established human lines like HeLa, HEK293, and CHO must be performed at Biosafety Level 2 according to international guidelines. Even well-characterized lines may harbor endogenous retroviruses, latent herpesviruses such as Epstein-Barr virus, human cytomegalovirus, or adventitious agents introduced via bovine serum or mycoplasma contamination. Furthermore, cell line cross-contamination, as historically documented for HeLa overgrowth, poses risks. BSL-2 provides appropriate containment without impairing workflow: access restricted to trained personnel, use of Class II BSC for trypsinization, media changes, pipetting that generates aerosols, mandatory PPE including gloves and lab gowns, biosafety training records, biohazard labels on incubators, and decontamination of liquid waste with bleach or autoclaving. BSL-1 is limited to defined non-pathogenic organisms such as E. coli K-12, while BSL-3 and BSL-4 are reserved for agents causing serious airborne disease like Mycobacterium tuberculosis or Ebola. Therefore BSL-2 represents standard for mammalian cell culture. Certification of cabinets annually and training logs documented in laboratory biosafety manual reinforce adherence. This knowledge strengthens laboratory safety, protocol reproducibility, and regulatory compliance critical for translational research and clinical applications, ensuring reliable data and workforce protection.

Ref: NIH Guidelines for Research Involving Recombinant DNA, Appendix G-II-BSL2; ATCC BSL-2 for animal cell lines. https://www.cdc.gov/labs/BMBL.html

The concept that all human samples are potentially infectious is called:

Universal precautions, now incorporated into Standard Precautions, embodies the principle that all human blood, body fluids except sweat, unfixed tissues, organs, and cell cultures should be regarded as infectious regardless of donor history or test results. Concept formalized by CDC in 1987 during HIV epidemic to protect healthcare and laboratory workers from occupational transmission. Rationale is that serological window periods, asymptomatic carriers, and unknown agents prevent absolute assurance of safety. Implementation requires barrier protection including gloves, laboratory coats, face masks and goggles when splashing anticipated, hand hygiene after glove removal, prohibition of mouth pipetting, safe handling and disposal of sharps in puncture-resistant containers, decontamination of work surfaces with EPA-approved disinfectants, use of biosafety cabinets for manipulations that may create aerosols, and prompt reporting of exposures. Training, medical surveillance, and availability of post-exposure prophylaxis complete program. This doctrine justifies treating routine cell culture as BSL-2 and underpins OSHA Bloodborne Pathogens Standard 29 CFR 1910.1030.

Ref: CDC Universal Precautions for Preventing Transmission of Bloodborne Infections, MMWR 1988; OSHA 29 CFR 1910.1030. https://www.cdc.gov/mmwr

All unfixed human tissues and cells should be handled using:

Unfixed human tissues, blood, body fluids and all primary or continuous human cell lines must be manipulated under Biosafety Level 2 as stipulated by CDC/NIH Biosafety in Microbiological and Biomedical Laboratories. This requirement originates from unavoidable risk of bloodborne pathogens including HIV, HBV, HCV, HTLV and emerging viruses that may be present without clinical signs. Latent herpesviruses such as EBV and CMV also persist in donors. BSL-2 practices mandate use of Class II biological safety cabinets with HEPA-filtered laminar flow for any aerosol-generating procedures, limited laboratory access, biohazard signage, mandatory personal protective equipment including gloves and lab coats, eye protection when splashing possible, availability of autoclave for waste decontamination, and use of effective disinfectants like 10% bleach. Personnel require bloodborne pathogen training and HBV vaccination. Liquid waste is chemically disinfected. Unlike BSL-1 reserved for non-pathogenic lab strains, BSL-2 addresses moderate risk. Fixed paraffin-embedded tissues are exempt after complete fixation. Fixation with formalin inactivates most pathogens rendering samples safer for histology processing outside biosafety cabinets. This knowledge strengthens laboratory safety, protocol reproducibility, and regulatory compliance critical for translational research and clinical applications, ensuring reliable data and workforce protection.

Ref: CDC NIH BMBL 6th Ed. Section IV Lab Biosafety Level Criteria, Human Cell Lines; https://www.cdc.gov/labs/BMBL.html - BSL-2 for human tissues.